Dr. Robert T. Sataloff, M.D.
ENT (Otolaryngology) (Otology & Neurotology Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 80
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otology & Neurotology Physician primary
PA license MD018721E -
Otolaryngology Physician
PA license MD018721E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 80
- Services billed
- 227
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Treatment of speech, language, voice, communication, and/or hearing processing disorder | 201 | 37 |
| Exam to assess movement of vocal cord flaps using an endoscope | 193 | 96 |
| Established patient office or other outpatient visit, 20-29 minutes | 140 | 80 |
| Established patient office or other outpatient visit, 10-19 minutes | 85 | 58 |
| Established patient office or other outpatient visit, 30-39 minutes | 81 | 59 |
| Imaging of voice box with speech evaluation | 49 | 31 |
| Analysis of voice and resonance production | 34 | 32 |
| New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| Test for hearing various pitches using earphone | 27 | 21 |
| Test for ability to detect and repeat spoken words with speech recognition | 26 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Famotidine Other prescribers in Philadelphia, PA | 231 |
| Pantoprazole Sodium Other prescribers in Philadelphia, PA | 169 |
| Omeprazole Other prescribers in Philadelphia, PA | 42 |
| Esomeprazole Magnesium Other prescribers in Philadelphia, PA | 39 |
| Triamterene-Hydrochlorothiazid (triamterene/hydrochlorothiazid) Other prescribers in Philadelphia, PA | 27 |
| Rabeprazole Sodium Other prescribers in Philadelphia, PA | 25 |
| Lansoprazole Other prescribers in Philadelphia, PA | 21 |
| Methotrexate (methotrexate sodium) Other prescribers in Philadelphia, PA | 17 |
| Diazepam Other prescribers in Philadelphia, PA | 15 |
| Omeprazole-Sodium Bicarbonate (omeprazole/sodium bicarbonate) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $3,000 in total to this clinician.
| Precigen, Inc. | $3,000 |
|---|
| Consulting Fee | $3,000 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Precigen, Inc. Aug 21, 2025 | Consulting Fee PAPZIMEOS · Immunotherapy | $3,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $8,200 in research payments for these studies, mostly to the institutions running them.
- (OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation
Livanova USA, Inc. - OSPREY
Livanova USA, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.